Marex Group Ltd: VKTX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Marex Group Ltd on VKTX, newest first. How the timeline and the estimate are built.
Marex Group Ltd held 46,654 VKTX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 46,654 sharesChange vs previous 13F +14,343 shares
0.01% of the 13F portfolio, value $1,819,973.
13F-HR 0001997464-26-000070 filed by Marex Group Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 32,311 sharesChange vs previous 13F -4,116 shares
0.01% of the 13F portfolio, value $1,051,400.
13F-HR 0001997464-26-000058 filed by Marex Group Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 36,427 sharesChange vs previous 13F -2,813 shares
0.01% of the 13F portfolio, value $1,281,502.
13F-HR 0001997464-26-000002 filed by Marex Group Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 39,240 sharesChange vs previous 13F +2,136 shares
0.01% of the 13F portfolio, value $1,031,227.
13F-HR 0001997464-25-000068 filed by Marex Group Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 37,104 sharesChange vs previous 13F +20,390 shares
0.02% of the 13F portfolio, value $983,256.
13F-HR 0001997464-25-000052 filed by Marex Group Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 16,714 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $403,643.
13F-HR 0001997464-26-000040 filed by Marex Group Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).